611
|
|
|
Phospholipase A2 activating protein |
DOA1, NDMSBA, PLA2P, PLAP |
|
612
|
|
|
Phospholipase A and acyltransferase 2 |
HRASLS2, PLA1/2-2, PLAAT-2 |
|
613
|
|
|
Phospholipase A and acyltransferase 3 |
AdPLA, FPLD9, H-REV107, H-REV107-1, HRASLS3, HREV107, HREV107-1, HREV107-3, HRSL3, PLA2G16, PLAAT-3 |
|
614
|
|
|
Phospholipase A and acyltransferase 4 |
HRASLS4, HRSL4, PLA1/2-3, PLAAT-4, RARRES3, RIG1, TIG3 |
|
615
|
|
|
Placenta enriched 1 |
CT92, OOSP2B, OOSP2L |
|
616
|
|
|
Placenta associated 8 |
C15, DGIC, PNAS-144, onzin |
|
617
|
|
|
PLAG1 zinc finger |
PSA, SGPA, SRS4, ZNF912 |
|
618
|
|
|
PLAG1 like zinc finger 1 |
LOT1, ZAC, ZAC1 |
|
619
|
|
|
PLAG1 like zinc finger 2 |
ZNF900 |
|
620
|
|
|
Plasminogen activator, tissue type |
T-PA, TPA |
Amphetamine or sympathomimetic abuse, Angioedema, Antiphospholipid syndrome, Aphasia, Postictal aphasia, Arterial occlusive disease, Osteonecrosis of the femoral head, Atherosclerosis, Avascular necrosis of bone, Brain edema, Brain infarction, Brain ischemia, Cardiac tamponade, Cerebral hemorrhage, Ischemic stroke, Cerebral thrombosis, Cerebrovascular disorder, Cholesterol embolism, Commisural aphasia, Spinal cord compression, Congestive heart failure, Coronary thrombosis, Deep vein thrombosis, Dejerine-lichtheim phenomenon, Allergic contact dermatitis, Diabetes mellitus type 2, Diabetic angiopathies, Diabetic peripheral angiopathy, Dysphasia, Heart failure, Hematoma, Hemophilia a, Hemorrhage, Hypertension, Hypotension, Hypoxia, Intracranial embolism and thrombosis, Intracranial hemorrhage, Intracranial thrombosis, Myocardial infarction, Osteonecrosis of medial femoral condyle, Paresis, Pericardial effusion, Schizophrenia, Stroke, Syntactic aphasia, Systemic lupus erythematosus, Thrombocytopenia, Thromboembolism, Thrombophilia, Thrombosis, Intracranial vasospasm, Venous thromboembolism, Venous thrombosis, Ventricular dysfunction, Von willebrand disorderView all (41 more) |
